Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

FSTRP
90440
FSTSC
91984
STR
8746
design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996;174:752-759
3. Butler JC, Breiman RF, Lipman HB, et al: Serotype distribution of Streptococcus pneumoniae
infections among preschool children in the United States, 1978-1994: implications for development of a
conjugate vaccine. J Infect Dis 1995;171:885-889 4. Butler JC, Hoffman J, Cetron MS, et al: The
continued emergence of drug-resistant Streptococcus pneumoniae in the United States. An update from
the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect
Dis 1996;174:986-993 5. Jacob GL, Homburger HA: Simultaneous Quantitative Measurement of IgG
Antibodies to Streptococcus Pneumoniae Serotypes by Microsphere Photometry. J Allergy Clin
Immunol,2004;113(2) Suppl (Abstract 1049, pS288) 6.Table 2: Geometric mean concentrations
(ug/mL) of pneumococcal antibodies following the third and fourth doses of Prevnar or control when
administered concurrently with DTP-HbOC in the efficacy study. In Physician's Desk Reference 2003.
57th edition. Montvale, NJ, Thompson PDR, p 3455 7. Plikaytis BD, Holder PF, Pais LB, et al:
Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiology 1994
October;32:2441-2447 8. Plikaytis BD, Goldblatt D, Frasch CE, et al: An analytical model applied to a
multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiology 2000
June;38(6):2043-2050
Streptomycin, HPLC
Reference Values:
Drug concentrations are expressed in mcg/mL.
Following intramuscular injection of 1 g of streptomycin as the
sulfate, a peak serum level of 25 to 50 mcg/mL is reached within
1 hour.
Test Performed by: Focus Diagnostics, Inc.
5785 Corporate Avenue
Cypress, CA 90630-4750
Streptozyme Screen with Reflex to Titer
Reference Values:
Negative
Test Performed by: Focus Diagnostics, Inc.
5785 Corporate Ave.
Cypress, CA 90630-4750
Striational (Striated Muscle) Antibodies, Serum
Clinical Information: Autoantibodies directed against the contractile elements of striated muscle are
found in 30% of adult patients with myasthenia gravis and in 80% of those with thymoma. These
antibodies may also be detected in patients with: Lambert-Eaton myasthenic syndrome, small-cell lung
carcinoma, breast carcinoma, patients treated with D-penicillamine, bone marrow transplant recipients
having graft-versus-host disease, and autoimmune liver disorders.
Useful For: This test is a useful serological aid in the diagnosis of thymoma, especially in patients with
onset of myasthenia gravis (MG) younger than 45 years. It is more predictive of thymoma when
accompanied by a muscle acetylcholine receptor (AChR) modulating antibody value of > or =90% AChR
loss and is most predictive of thymoma when accompanied by CRMP-5-IgG. It is useful as a screening
test for MG in older patients, especially when tests for muscle AChR antibodies are negative. Serial
measurements are useful in monitoring the efficacy of immunosuppressant treatment in patients with MG.
Serial measurements are useful after treatment of thymoma. Measurements of muscle AChR binding,
muscle AChR modulating antibody, and CRMP-5-IgG (if initially positive) are also recommended. Serial
Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1642